You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 202080

✉ Email this page to a colleague

« Back to Dashboard

NDA 202080 describes OXAYDO, which is a drug marketed by Zyla and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the OXAYDO profile page.

The generic ingredient in OXAYDO is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.

Summary for 202080

Tradename:	OXAYDO
Applicant:	Zyla
Ingredient:	oxycodone hydrochloride
Patents:	2

Pharmacology for NDA: 202080

Mechanism of Action	Full Opioid Agonists

Suppliers and Packaging for NDA: 202080

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080	NDA	Zyla Life Sciences US LLC	69344-113	69344-113-11	100 TABLET in 1 BOTTLE (69344-113-11)
OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080	NDA	Zyla Life Sciences US LLC	69344-213	69344-213-11	100 TABLET in 1 BOTTLE (69344-213-11)

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Jun 17, 2011	TE:		RLD:	Yes
Patent:	⤷ Sign Up	Patent Expiration:	Mar 16, 2025	Product Flag?	Y	Substance Flag?		Delist Request?
Patent:	⤷ Sign Up	Patent Expiration:	May 26, 2024	Product Flag?	Y	Substance Flag?		Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	7.5MG
Approval Date:	Jun 17, 2011	TE:		RLD:	Yes
Patent:	⤷ Sign Up	Patent Expiration:	Mar 16, 2025	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 202080

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-002	Jun 17, 2011	⤷ Sign Up	⤷ Sign Up
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-002	Jun 17, 2011	⤷ Sign Up	⤷ Sign Up
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-001	Jun 17, 2011	⤷ Sign Up	⤷ Sign Up
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-001	Jun 17, 2011	⤷ Sign Up	⤷ Sign Up
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-001	Jun 17, 2011	⤷ Sign Up	⤷ Sign Up
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-002	Jun 17, 2011	⤷ Sign Up	⤷ Sign Up
Zyla	OXAYDO	oxycodone hydrochloride	TABLET;ORAL	202080-001	Jun 17, 2011	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.